Efficacy of Ivermectin Treatment on Disease Progression Among Adults With Mild to Moderate COVID-19 and Comorbidities: The I-TECH Randomized Clinical Trial – JAMA Internal Medicine Commentaries: Ivermectin doesn’t prevent severe disease from Covid-19, new study finds – CNN Ivermectin futile for mild to moderate COVID-19, study finds – CIDRAP Related: Case Series: Toxic effects from […]

The post RCT: In patients with mild to moderate Covid-19 and comorbidities, treatment with Ivermectin did not reduce the risk of disease progression. appeared first on Links Medicus.